Method of manufacturing polymer-free everolimus-eluting coronary stent fabricated by electrospinning technique
US9795987B1 · kind B1 · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 2016 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Aug 29, 2036 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB05D2254/00
- WIPO fieldSurface technology, coating
- WIPO sectorChemistry
Abstract
Provided is a drug-eluting coronary stent. In the drug-eluting coronary stent according to the present invention, electrospinning is used, thereby making it possible to precisely control a total content of an everolimus-based drug bound thereto and form a uniform layer in spite of not using a polymer causing late thrombosis, or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.